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The current role of liver transplantation in treating malignant 
tumors of the liver is uncertain, except for select histologic types. 
Pooled data on the results of liver transplantation in 12 children 
with hepatoblastoma is presented here. One haIf of the children 
are alive 24 to 70 (44 ± 19) months after transplantation with 
no evidence of recurrence. Three patients (25%) died of tumor 
recurrence and three (25%) died of other causes. Unifocal and 
intrahepatic tumors were associated with better prognosis com-
pared to the multifocal tumors and tumors with extrahepatic 
spread (p = 0.04 and 0.13). Microscopically vascular invasion 
and the predominance of embryonal and/or anaplastic epithelium 
were associated with a poor prognosis compared to the tumors 
with no vascular invasion and with predominantly fetal epithelium 
(p = 0.08 and 0.1). It is concluded that continued efforts to treat 
unresectable hepatoblastomas by liver transplantation is justified 
and the role of adjuvant chemotherapy in improving the results 
needs to be better defined. 
A T THE TIME of the initial trials of clinical liver transplantation, the ideal indication was per-
ceived to be a malignant tumor confined to the 
liver that could not be removed with partial hepatic re-
section. 1.2 However efforts to apply this concept were dis-
illusioning because the incidence of recurrence after or-
thotopic liver transplantation was very high.3 Nevertheless 
some malignant tumors in adults have been treated ef-
fectively with total hepatectomy and replacement of the 
liver.4- 7 
The possibility that hepatoblastoma should be consid-
ered in a special category was suggested by anecdotal ac-
counts of children surviving for long periods after liver 
replacement for this indication. However there are no re-
ports of a significant number of cases as to the long-term 
results of liver transplantation for hepatoblastoma.7 We 
report here observations in 12 children with hepatoblas-
tomas who were treated by liver transplantation in the 
United States. 
Case Material 
As of August 1988, 12 children had received 13 liver 
grafts for hepatoblastoma in 10 different medical centers 
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in the United States. Data were collected on all patients 
regarding age, sex, previous liver resection, chemotherapy 
before and after the transplant, extent of gross disease at 
the time of transplant, recurrence after the transplant, 
and the patients' current clinical status (Table 1). Infor-
mation on the histologic features of the tumors was ob-
tained through review of the surgical pathology reports 
and, when necessary, by direct contact with the examining 
pathologists. 
The 12 children were aged from 6 months to 11 years 
(42 ± 33 months); 6 were girls. Four underwent a hepatic 
resection 9 to 20 months before their transplant in an 
attempt to control the tumor. All children had markedly 
elevated serum alpha-feto-protein levels at the time of 
their transplantation. Only 1 of the 12 children had cir-
rhosis. 
Extent of Gross Disease at Transplantation 
The disease was entirely intrahepatic in six patients. 
Although another three patients had intrahepatic tumor, 
a tumor thrombus was also present in the main portal 
vein. The remaining three patients were thought to have 
direct extrahepatic tumor invasion at the time of surgery. 
However, in one of these patients, the excised portion of 
the right hemidiaphragm was merely adherent to the tu-
mor with no histologic invasion. In seven patients with 
multifocal tumors the largest of the nodules measured 2.5 
to 9.0 (m = 5.4) cm. Five patients had unifocal tumors 
infiltrating both lobes and/or the hilum of the liver. The 
size ofthese tumors varied form 5 to 18 (m = 12) cm in 
diameter. 
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TABLE 1. Patients with Hepatoblastoma Treated by Liver Transplantation 
Prior 
Age, Hepatic Pre-TX Post-TX 
Sex Resection Chemo. Gross Disease Histologic Features Chemo. Recurrence Status 
1.75 yrs. Yes Yes IH Predominantly F No No Died of Pneumocystis 
M Unifocal No vascular invasion Pneumonitis; 9 mos. 
4.5 yrs. Yes Yes IH +TT F+E Yes Yes Died of recurrence; 23 
M Multifocal Vascular invasion+ Peritoneum; brain mos. 
5 yrs. Yes Yes IH +TT Predominantly E No No Died of hepatic artery 
F Multifocal Vascular invasion+ thrombosis; 15 days 
0.5 yrs. No No IH; Unifocal E + A; No vascular No No Died of hepatic artery 
M invasion thrombosis; 4 mos. 
1.5 yrs. No No IH; Unifocal F; No vascular No No Alive; 66 mos. 
F invasion 
4 yrs. Yes Yes IH E; Vascular invasion+ No Yes Died of recurrence; 4 mos. 
M Multifocal Lungs; liver 
11 yrs. No Yes IH; Unifocal F + E; No vascular Yes No Alive; 30 mos. 
F invasion 
5 yrs. No Yes IH A; Vascular No No Alive; 43 mos. 
M Multifocal invasion + 
3 yrs. No Yes IH +TT Predominantly F Yes No Alive; 32 mos. 
F Unifocal Vascular invasion+ 
2.5 yrs. No No EH F + E; Vascular Yes No Alive; 24 mos. 
F MuItifocal invasion+ 
2 yrs. No Yes EH + Multifocal F+E+A No Yes Died of recurrence; 35 days 
F Vascular invasion+ Brain; lungs 
Lymph node+ 
2.3 yrs. No Yes IH E + A; Vascular 
M Multifocal invasion + 
IH, intrahepatic; EH, extra hepatic extension; TT, tumor thrombus 
Histologic Characteristics 
In nine (75%) patients, the tumors contained only ep-
ithelial elements. In three (25%), a variable amount of 
mesenchymal components also were present. Three pa-
tients had a purely or predominantly fetal epithelium. 
Embryonal and anaplastic epithelial patterns predomi-
nated in two patients each. There was an admixture of 
two or three epithelial patterns with no pattern predom-
inating in five (42%) patients. Anaplastic epithelium was 
a component in three of these latter five patients. 
Vascular invasion was evident microscopically in eight 
patients, including all three with tumor thrombii in the 
main portal vein. Only one child in the group of 12 had 
lymph node metastases and positive hepatic resection 
margins. Her tumor extensively infiltrated the rectus 
sheath, diaphragm and the pericardium. 
Chemotherapy 
Nine patients received chemotherapy before and five 
after the transplant under different protocols (Table 1). 
Statistical Analysis 
The median patient survival rate was calculated among 
the various groups and a non parametric test (log rank 
Yes Yes Alive; 70 mos. 
Pulmonary 
7 mos. 
in the main portal vein; F, fetal epithelium; E, embryonal epithelium; 
A, anaplastic epithelium. 
test) was used to assess the statistical significance of the 
differences in the length of survival. A p value of 0.05 or 
less was considered significant. 
Results 
Survival 
Six of the twelve children with hepatoblastoma died 
after transplant. Three died due to recurrent disease at 35 
days, 4 and 23 months after transplantation. All three had 
multiple sites of recurrence. Two children died of allograft 
hepatic artery thrombosis, one despite retransplantation, 
15 days and 4 months after operation, respectively. The 
sixth child died of Pneumocystis pneumonitis 9 months 
after transplantation. Autopsies performed in the latter 
two patients did not reveal any evidence of tumor. 
The remaining six children are alive 24 to 70 (44 ± 19) 
months after transplantation with no evidence of malig-
nancy. The longest surviving child developed a solitary 
pulmonary metastasis 7 months after his transplant de-
spite adjuvant post-transplant chemotherapy. This was 
resected and he remains tumor free with 70 months of 
follow-up. All survivors have had good allograft function. 
One patient developed a lymphoproiiferative disorder 2 
years after transplantation that resolved with the reduction 
of cyclosporine. 
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The deaths due to recurrent disease and the duration 
of survival have been analyzed further in relation to the 
factors listed below. 
(1) Previous liver resection: two of the four patients 
(50%) who underwent hepatic resection before the trans-
plant died of recurrent tumor compared to one of the 
eight patients (13%) without a previous resection. 
(2) Extent of gross disease (Table 2): in children with 
unifocal tumors, no deaths occurred due to recurrent dis-
ease and they survived significantly longer than did those 
children with multi focal tumors (p = 0.04). Similarly in-
trahepatic tumors had a better prognosis than did tumors 
manifesting portal vein tumor thrombus or direct extra-
hepatic invasion. The difference in their median survival 
times, however, did not reach statistical significance (p 
= 0.13). The child with lymph node involvement died of 
cerebral metastases 35 days after the transplantation. 
(3) Histology (Table 2): microscopic evidence of vas-
cular invasion and the presence of embryonal and/or an-
aplastic epithelium in the tumors were associated with 
poor prognosis. These differences, however, did not reach 
statistical significance (p = 0.08 and 0.1, respectively). 
(4) Chemotherapy: three of the nine children who re-
ceived chemotherapy before transplantation died of re-
currence. One of the five (20%) children who received 
post-transplant chemotherapy and two ofthe seven (28%) 
who did not receive chemotherapy died as a result of re-
current tumor. 
Discussion 
Hepatoblastoma is the most common primary malig-
nant liver tumor in children younger than 5 years.8,9 Par-
TABLE 2. Extent a/Gross Disease and Histologic Features Correlated 
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30 p = 0.04 
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30 p = 0.13 
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14.5 p = 0.08 
19.5 
32 p = 0.10 
5 
tial hepatic resection is the standard form of curative ther-
apy. In recent years preoperative chemotherapy has al-
. f . I t bl t 10-12 lowed resectwn 0 prevwus y unresec a e umors. 
Total hepatectomy and orthotopic liver transplantation 
becomes a rational choice for tumors that are unresectable 
by conventional means. Application of this concept to 
treat unresectable hepatocellular carcinoma has had a high 
incidence of recurrence and death after transplanta-
tion.2- 7 Long-term survival after transplantation for he-
patoblastoma previously has been reported only for one 
patient surviving 6 years after transplantation.7 
The results ofliver transplantation for hepatoblastoma 
in this series is inferior compared to the overall survival 
rate of pediatric liver recipients (58% versus 71 % 2-year 
survival rate). 13 However this compares favorably to the 
20% to 30% 2-year survival rates reported after trans-
. I' 37 plantatlOn for hepatocellu ar carcmoma .. 
Children who had a hepatic resection before transplan-
tation appeared to have worse prognoses compared to the 
children who did not. The reason is unknown but might 
be due to the more aggressive nature of the recurrent tu-
mors. Various clinicopathologic correlations have been 
made to identify prognostic factors that affect survival in 
children with hepatoblastoma. The size ofthe tumor alone 
has not been shown to be significant as long as it is re-
sectable.9•14 In this series the unifocal tumors were gen-
erally much larger than the multifocal tumors (d = 12 cm 
versus 5.4 cm) but had a significantly better prognosis. 
Extent of gross disease evident at surgery appears to have 
a definite impact on survival after transplantation. Patients 
with only intrahepatic tumors had better survival rates 
compared to the patients with extrahepatic extension. 
Kasai and Watanabe 15 and subsequently other 
authors8,14,16-18 reported the favorable prognosis associated 
with fetal epithelium in the tumors compared to that for 
the embryonal and anaplastic types. In this series also, 
patients with pure or predominantly fetal epithelial tumors 
did better. Vascular invasion had a negative impact on 
survival. The percentage of tumors containing mesen-
chymal elements varies among various reports and their 
. "fi . . 15 18 19 I thO t d prognostIc slgm cance IS uncertam. ,. n IS s u y 
the presence of mesenchymal elements in the tumors did 
not appear to affect the prognosis. 
Reduced rates of recurrence have been reported with 
combination chemotherapy following a curative resection 
for hepatablastoma. 12 However our observations regarding 
the role of chemotherapy are inconclusive because of the 
small number of patients in each group and also because 
of the different protocols used. 
In conclusion liver transplantation should be consid-
ered for non metastatic unresectable hepatoblastoma. The 
future role of pre- and post-transplant chemotherapy in 
improving the results remains to be defined. 
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